Evidence map›Paper›PMID 22647376›Full record

ArticleAutophagy2012

Not all autophagy is equal.

Maria F Czyzyk-Krzeska, Jarek Meller, David R Plas

Open access · bronzeAbstract readComment
In one paragraph

Article in Autophagy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. lncSNHG16 promotes hepatocellular carcinoma development by inhibiting autophagy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Maria F Czyzyk-KrzeskaDepartment of Cancer and Cell Biology, University of Cincinnati College of Medicine, Cincinnati, OH, USA. Maria.Czyzykkrzeska@uc.edu
Jarek Meller
David R Plas
University of Cincinnati Medical Center · USOncology Hematology Care · US

Funding

Role of ubiquitylation in renal cancerR01CA122346 · NCI · UNIVERSITY OF CINCINNATI · PI CZYZYK-KRZESKA, MARIA F · 2007 to 2017
$3.0M
NCI NIH HHS CA122346NCI NIH HHS R01 CA122346
6 · The paper itself

Abstract

Autophagy is an important mechanism in cancer cell survival and tumor growth and plays both pro- and anti-oncogenic roles. However, the biochemical basis for these diverse functions is not well understood. Our work provides new evidence for the existence of two separate autophagic programs regulated in an opposite manner by the von Hippel-Lindau tumor suppressor (VHL). These programs, marked by differential requirements for LC3B vs. LC3C, play tumor-promoting and tumor-suppressing roles in renal cancer.

Indexed as

AnimalsAutophagyCarcinoma, Renal CellHumansKidney NeoplasmsMicroRNAsMicrotubule-Associated ProteinsVon Hippel-Lindau Tumor Suppressor ProteinMicroRNAsMicrotubule-Associated ProteinsVon Hippel-Lindau Tumor Suppressor ProteinautophagyHIFLC3B/LC3Crenal cancerVHL

Identifiers

PMID22647376
PMCPMC3429557
OpenAlexW2053913499

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.